Temporary intraluminal bypass device designed to reduce the rate of diverting st...
Temporary intraluminal bypass device designed to reduce the rate of diverting stoma and its related complication by at least 70%
Anastomotic leakage of colon content into the abdominal cavity is the most devastating complication associated with colorectal surgery. Leaks occur in ~22% of cases, leading to increased hospitalization time, higher re-operation r...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
FlowAssist Pouch
FlowAssist Pouch will help to improve the skin condition of...
4M€
Cerrado
aortoseal
A minimally invasive and durable endograft fastening solutio...
6M€
Cerrado
apyx
The first non-surgical repair for Pelvic Organ Prolapse
5M€
Cerrado
Información proyecto CG-100
Duración del proyecto: 22 meses
Fecha Inicio: 2022-07-27
Fecha Fin: 2024-05-31
Líder del proyecto
COLOSPAN LTD
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
3M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Anastomotic leakage of colon content into the abdominal cavity is the most devastating complication associated with colorectal surgery. Leaks occur in ~22% of cases, leading to increased hospitalization time, higher re-operation rates, increased patient mortality & additional costs.
To minimize the risk of a leak, surgeons create a loop of the small bowel which is diverted outside the abdominal wall & connected to a stoma bag to collect patient’s feces for 4-6 months. Diverting stoma significantly diminishes patients’ quality of life, increases cost of care &
requires an additional invasive surgery to reverse the stoma. Our novel device, CG-100, is an elastic tubular sheath that is positioned at the anastomosis site during the primary colorectal surgery & creates an internal bypass for all colon content. CG-100 is removed non-surgically 10
days after primary surgery. CG-100 addresses will improve patient quality of life, save ~1350 pa lives & reduce healthcare costs by €4B pa in EU.